Zdrowie i gospodarka · 17/09/2025
FDA Announces Draft Guidance for Symptomatic Nonerosive Gastroesophageal Reflux Disease Treatment
The FDA has released a draft guidance outlining its recommendations for developing drugs to treat symptomatic nonerosive gastroesophageal reflux disease in adults, including clinical trial design and efficacy evaluations.